Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

University of Pavia36 enrolled

Overview

Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetes End Stage Renal Disease

Interventions

Continuous Glucose Monitoring (CGM)DEVICE

CGM allocated one time for 3 days

Eligibility

Sex: ALLMin age: 50 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with or without diabetes mellitus * ESRD * undergone hemodialysis * males and females aged 50-80 Exclusion Criteria: * tumors * chronic inflammation diseases * AMI * acute pulmonary diseases

Locations (1)

IRCCS Policlinico San Matteo

Pavia, Italy

Outcomes

Primary Outcomes

-Hemodialysis tolerability -Hypoglycemia numbers -Hyperglycemia numbers -Inflammation markers

Time frame: before and after each procedure

Secondary Outcomes

variations of glycemia during the night; insulin-sensitivity

Time frame: at the beginning of the first hemodialysis and at the end of the second hemodialysis

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.